Refine
Is part of the Bibliography
- yes (76)
Year of publication
Document Type
- Journal article (72)
- Conference Proceeding (4)
Keywords
- Chirurgie (5)
- Langerhans-Inseln (4)
- Transplantation (4)
- HNSCC (3)
- Schwein (3)
- brain (3)
- head and neck cancer (3)
- Antikörper (2)
- Bauchspeicheldrüse (2)
- Biochemie (2)
- Cancer (2)
- HGF (2)
- Medizin (2)
- Met (2)
- Toxikologie (2)
- biodiversity (2)
- cancer (2)
- cancer metabolism (2)
- cytokines (2)
- genome-wide association (2)
- 1 (1)
- 2-Dioxetane (1)
- 3D modeling (1)
- 5-HTTLPR (1)
- AMPK (1)
- Agent (1)
- Alpha therapy (1)
- Apoptosis (1)
- Autoimmune diseases (1)
- Bartak (1)
- Bauspeicheldrüse (1)
- Benzefuran dioxetane (1)
- Benzefuran epoxide (1)
- Berger-Parker (1)
- Bone marrow transplantantation (1)
- Breast-tumors (1)
- Bullous pemphigoid (1)
- CD44 (1)
- CD74 (1)
- CML (1)
- COX-2 (1)
- Calcineurin-NFATsignaling (1)
- Ceramide (1)
- Compound 3k (1)
- Cone-beam CT (1)
- DASA-58 (1)
- DFNB68 (1)
- DNA adduct . Repair endonuclease (1)
- DNA barcoding (1)
- DNA damage (1)
- Expression (1)
- FPG protein (1)
- Factor receptor (1)
- First G-APD Cherenkov Telescope (1)
- Functional modules (1)
- Golgi (1)
- Graft-versus-leukemia (1)
- HLA class II (1)
- HLA peptidome (1)
- HUWE1 (1)
- Heterotransplantation (1)
- Hill's powers (1)
- Histologie (1)
- Image-guidance (1)
- Imaging Air Cherenkov Telescope (1)
- Immunoadsorption (1)
- Immunoapheresis (1)
- In-vivo (1)
- Inhibitor (1)
- Integrated network analysis (1)
- Inter-observer variability (1)
- Isolierung <Mikrobiologie> (1)
- Japanese population (1)
- Jurkat cells (1)
- Kollagenase (1)
- Krebs (1)
- LND (1)
- LNE (1)
- Lung cancer (1)
- MFM (1)
- MHC Klasse II (1)
- MIZ1 (1)
- MTCH2 (1)
- MYC (1)
- Malaise trap (1)
- Metabolic pathways (1)
- Metabolic profiles (1)
- Milnesium tardigradum (1)
- Mutagenicity (1)
- N-oleoyl serinol (1)
- NHX1 (1)
- NK cells (1)
- NaCl transport (1)
- Niere (1)
- Nude-mice (1)
- PD-L1 (1)
- PKM2 (1)
- Pakistan (1)
- RNA (1)
- Ratte (1)
- Regulatory-cells (1)
- Respiration correlated imaging (1)
- Rheumatoid arthritis (1)
- S1PR2 (1)
- SLC6A4 (1)
- SUMO2 (1)
- Salmonella Typhimurium (1)
- Salt Overly Sensitive pathway (1)
- Suppression (1)
- T cells (1)
- TIC disorders (1)
- TXNIP (1)
- Tissue (1)
- Townes (1)
- Transplantat (1)
- Trend test (1)
- Tumor-necrosis-factor (1)
- VAL66MET polymorphism (1)
- Virologie (1)
- Warburg effect (1)
- activation (1)
- adaption (1)
- adrenal cancer (1)
- adrenocortical carcinoma (1)
- adsorption (1)
- allogeneic hematopoietic stem cell transplantation (1)
- animal behaviour (1)
- animal experimentation (1)
- animal model (1)
- antidepressant (1)
- apoptosis (1)
- arbuscular mycorrhizal fungi (1)
- arteriovenous extracorporeal hemadsorption technique (1)
- arthropods (1)
- association (1)
- autism (1)
- autosomal recessive non-synstromic hearing loss (1)
- auxin (1)
- bcl-2 associated athanogene protein 3 (1)
- betaglycan (1)
- bipolar disorder (1)
- blood purification (1)
- bone regeneration (1)
- borates (1)
- brain metastasis (1)
- calcium phosphate cement (1)
- calcium signaling (1)
- candidate gene (1)
- carbon fiber reinforcement (1)
- cardiac hypertrophy (1)
- case report (1)
- chemical diversity (1)
- chronic myeloid leukemia (1)
- classification (1)
- cluster (1)
- colorectal cancer (1)
- common SNPS (1)
- complex diseases (1)
- consanguinity (1)
- conservation biology (1)
- coordination polymers (1)
- coreceptor (1)
- correlate (1)
- cytosolic pH (1)
- damage tolerant cement (1)
- database (1)
- developmental dyscalculia (1)
- diarrhea (1)
- digestive system (1)
- disability (1)
- disease (1)
- disorders (1)
- drug discovery (1)
- drug treatment (1)
- dyscalculia (1)
- dyslexia (1)
- early respiratory-failure (1)
- efficacy (1)
- endotoxin (1)
- enzyme activation (1)
- enzyme inhibitors (1)
- essential tremor (1)
- exome sequencing (1)
- expressed sequence tag (1)
- expression (1)
- expression signature (1)
- extracorporeal hemadsorption (1)
- extracorporeal techniques in hemadsorption therapy (1)
- family (1)
- fiber–matrix interaction (1)
- gene expression (1)
- genetic diagnosis (1)
- genetics (1)
- genome-wide association study (1)
- genome-wide linkage analysis (1)
- genomic imaging (1)
- genotype (1)
- gilles (1)
- glycolysis (1)
- glycoprotein (1)
- growth factor beta (1)
- guided bone regeneration (1)
- halophyte (1)
- hearing impairment (1)
- hearing loss (1)
- helimagnets (1)
- identification (1)
- immune response (1)
- immune therapy (1)
- immunosorbents (1)
- inelastic neutron scattering (1)
- insect communities (1)
- insect monitoring (1)
- interface control (1)
- intraosseous (1)
- invasive species (1)
- ionic liquids (1)
- islets of Langerhans (1)
- kidney (1)
- lanthanides (1)
- leaf response (1)
- leishmania major (1)
- ligand binding (1)
- long-term monitoring (1)
- luminescence (1)
- lymph node dissection (1)
- lymph nodes (1)
- lymphadenectomy (1)
- lymphoma (1)
- major depressive disorder (1)
- mandible (1)
- markers (1)
- mathematics (1)
- melt electrospinning writing (1)
- messenger RNA (1)
- meta-analysis (1)
- metabarcoding (1)
- metastasis (1)
- missing heritability (1)
- mixed hearing loss (1)
- modules (1)
- molecular diversity (1)
- monitoring (1)
- mood disorder (1)
- mouse models (1)
- movement disorders (1)
- mucosal inflammation (1)
- multiparametric magnetic resonance imaging (1)
- muscular-dystrophy (1)
- mutagenesis (1)
- myasthenia gravis (1)
- myopathy (1)
- neovascularization, physiologic (1)
- neuropsychiatric disorders (1)
- neurotrophic factor gene (1)
- next generation sequencing (1)
- osmotic effects (1)
- parasitic diseases (1)
- permeation and transport (1)
- pest species (1)
- pharmacogenetics (1)
- pharmacology (1)
- phase conversion (1)
- physics (1)
- plant diversity (1)
- plantago lanceolata (1)
- polar ion transport (1)
- polycaprolactone (1)
- polymerization (1)
- polyneuropathy (1)
- prelevance (1)
- protein aggregation (1)
- protein familiy (1)
- protein-interaction networks (1)
- proteins (1)
- pseudocarcinomatous hyperplasia (1)
- quality-control (1)
- quantitative trait (1)
- quinoa (1)
- rat (1)
- receptor type III (1)
- review (1)
- salt stress (1)
- salt tolerance (1)
- scaffold (1)
- secretion (1)
- septic shock (1)
- sequence variations (1)
- set (1)
- shannon index (1)
- silicon photo multiplier (1)
- simpson's index (1)
- skeletal myopathy (1)
- spin waves (1)
- stability (1)
- stalk cell (1)
- stem cell transplantation (1)
- sulcal morphology (1)
- superfamily (1)
- survival (1)
- swine (1)
- tardigrada (1)
- targeted (1)
- thymic carcinoma (1)
- thymoma (1)
- thymus (1)
- tissue engineering (1)
- tolerability (1)
- tool (1)
- transcriptome (1)
- translational medical research (1)
- trap selectivity (1)
- treatment response (1)
- tremor (1)
- tumor infiltrating lymphocytes (1)
- tumor-suppressor gene (1)
- tyrosine kinase inhibitors (1)
- ubiquitination (1)
- very high energy gamma rays (1)
- whole exome sequencing (1)
- xenogenic transplantation (1)
- α-tricalcium phosphate (1)
Institute
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (25)
- Theodor-Boveri-Institut für Biowissenschaften (16)
- Institut für Virologie und Immunbiologie (5)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (5)
- Pathologisches Institut (4)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (3)
- Institut für Humangenetik (3)
- Institut für Molekulare Infektionsbiologie (3)
- Julius-von-Sachs-Institut für Biowissenschaften (3)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (3)
Sonstige beteiligte Institutionen
The direct estimation of heritability from genome-wide common variant data as implemented in the program Genome-wide Complex Trait Analysis (GCTA) has provided a means to quantify heritability attributable to all interrogated variants. We have quantified the variance in liability to disease explained by all SNPs for two phenotypically-related neurobehavioral disorders, obsessive-compulsive disorder (OCD) and Tourette Syndrome (TS), using GCTA. Our analysis yielded a heritability point estimate of 0.58 (se = 0.09, p = 5.64e-12) for TS, and 0.37 (se = 0.07, p = 1.5e-07) for OCD. In addition, we conducted multiple genomic partitioning analyses to identify genomic elements that concentrate this heritability. We examined genomic architectures of TS and OCD by chromosome, MAF bin, and functional annotations. In addition, we assessed heritability for early onset and adult onset OCD. Among other notable results, we found that SNPs with a minor allele frequency of less than 5% accounted for 21% of the TS heritability and 0% of the OCD heritability. Additionally, we identified a significant contribution to TS and OCD heritability by variants significantly associated with gene expression in two regions of the brain (parietal cortex and cerebellum) for which we had available expression quantitative trait loci (eQTLs). Finally we analyzed the genetic correlation between TS and OCD, revealing a genetic correlation of 0.41 (se = 0.15, p = 0.002). These results are very close to previous heritability estimates for TS and OCD based on twin and family studies, suggesting that very little, if any, heritability is truly missing (i.e., unassayed) from TS and OCD GWAS studies of common variation. The results also indicate that there is some genetic overlap between these two phenotypically-related neuropsychiatric disorders, but suggest that the two disorders have distinct genetic architectures.
A recent genome-wide association study in patients with panic disorder (PD) identified a risk haplotype consisting of two single-nucleotide polymorphisms (SNPs) (rs7309727 and rs11060369) located in intron 3 of TMEM132D to be associated with PD in three independent samples. Now we report a subsequent confirmation study using five additional PD case-control samples (n = 1670 cases and n 2266 controls) assembled as part of the Panic Disorder International Consortium (PanIC) study for a total of 2678 cases and 3262 controls in the analysis. In the new independent samples of European ancestry (EA), the association of rs7309727 and the risk haplotype rs7309727-rs11060369 was, indeed, replicated, with the strongest signal coming from patients with primary PD, that is, patients without major psychiatric comorbidities (n 1038 cases and n 2411 controls). This finding was paralleled by the results of the meta-analysis across all samples, in which the risk haplotype and rs7309727 reached P-levels of P = 1.4e-8 and P = 1.1e-8, respectively, when restricting the samples to individuals of EA with primary PD. In the Japanese sample no associations with PD could be found. The present results support the initial finding that TMEM132D gene contributes to genetic susceptibility for PD in individuals of EA. Our results also indicate that patient ascertainment and genetic background could be important sources of heterogeneity modifying this association signal in different populations.
Low-energy spin excitations in any long-range ordered magnetic system in the absence of magnetocrystalline anisotropy are gapless Goldstone modes emanating from the ordering wave vectors. In helimagnets, these modes hybridize into the so-called helimagnon excitations. Here we employ neutron spectroscopy supported by theoretical calculations to investigate the magnetic excitation spectrum of the isotropic Heisenberg helimagnet \({ZnCr_2Se_4}\) with a cubic spinel structure, in which spin\(-3/2\) magnetic \({Cr^{3+}}\) ions are arranged in a geometrically frustrated pyrochlore sublattice. Apart from the conventional Goldstone mode emanating from the \((0~ 0~ {q_h})\) ordering vector, low-energy magnetic excitations in the single-domain proper-screw spiral phase show soft helimagnon modes with a small energy gap of \({∼0.17~ meV}\), emerging from two orthogonal wave vectors \(({q_h}~ 0~ 0)\) and \({(0~ {q_h}~ 0)}\) where no magnetic Bragg peaks are present. We term them pseudo-Goldstone magnons, as they appear gapless within linear spinwave theory and only acquire a finite gap due to higher-order quantum-fluctuation corrections. Our results are likely universal for a broad class of symmetric helimagnets, opening up a new way of studying weak magnon-magnon interactions with accessible spectroscopic methods.
We conducted a genome-wide association study of essential tremor, a common movement disorder characterized mainly by a postural and kinetic tremor of the upper extremities. Twin and family history studies show a high heritability for essential tremor. The molecular genetic determinants of essential tremor are unknown. We included 2807 patients and 6441 controls of European descent in our two-stage genome-wide association study. The 59 most significantly disease-associated markers of the discovery stage were genotyped in the replication stage. After Bonferroni correction two markers, one (rs10937625) located in the serine/threonine kinase STK32B and one (rs17590046) in the transcriptional coactivator PPARGC1A were associated with essential tremor. Three markers (rs12764057, rs10822974, rs7903491) in the cell-adhesion molecule CTNNA3 were significant in the combined analysis of both stages. The expression of STK32B was increased in the cerebellar cortex of patients and expression quantitative trait loci database mining showed association between the protective minor allele of rs10937625 and reduced expression in cerebellar cortex. We found no expression differences related to disease status or marker genotype for the other two genes. Replication of two lead single nucleotide polymorphisms of previous small genome-wide association studies (rs3794087 in SLC1A2, rs9652490 in LINGO1) did not confirm the association with essential tremor.
Tyrosine kinase inhibitors represent today's treatment of choice in chronic myeloid leukemia (CML). Allogeneic hematopoietic stem cell transplantation (HSCT) is regarded as salvage therapy. This prospective randomized CML-study IIIA recruited 669 patients with newly diagnosed CML between July 1997 and January 2004 from 143 centers. Of these, 427 patients were considered eligible for HSCT and were randomized by availability of a matched family donor between primary HSCT (group A; N=166 patients) and best available drug treatment (group B; N=261). Primary end point was long-term survival. Survival probabilities were not different between groups A and B (10-year survival: 0.76 (95% confidence interval (CI): 0.69–0.82) vs 0.69 (95% CI: 0.61–0.76)), but influenced by disease and transplant risk. Patients with a low transplant risk showed superior survival compared with patients with high- (P<0.001) and non-high-risk disease (P=0.047) in group B; after entering blast crisis, survival was not different with or without HSCT. Significantly more patients in group A were in molecular remission (56% vs 39%; P = 0.005) and free of drug treatment (56% vs 6%; P<0.001). Differences in symptoms and Karnofsky score were not significant. In the era of tyrosine kinase inhibitors, HSCT remains a valid option when both disease and transplant risk are considered.
The GVHRIL foHowing transplantation of small intestine are different from those found after bone marrow transplantation or spleen cell injections in that they show a remarka ble, significant prevalence of lesions within the intestinal mucosa. These findings are consistent with the observation that jntestinal lymphocytes newly formed in mesenteric lymph nodes predominantly home in on the intestine again.& The degree of histologic alteration within different tissues indicates that the graft and the host may survive the lesions of the lymphatic tissues, whereas the severe intestinal lesions following GVHR may easily cause death of the recipient. With regard to clinical sman bowel transplantation two statements can be made: (l) GVHRIL play a significant role in small bowel trans~ plantation. (2) To minimize their biologic importance, a selective elimination of the graft's Jymph nodes by irradiation or surgical resection should be considered in view of the remarkable difference between GVHRIL in lymph nodes and in the graft's intestinal wall itself.
The role of the thymus in the pathogenesis of simian acquired immunodeficiency syndrome was investigated in 18 juvenile rhesus monkeys (Macaca mulatta). The thymus was infected from the first week post-SIVmac inoculation, but the amount of virus-positive cells was very low « 1 in 1 04 T cells) as demonstrated by polymerase chain reaction and in situ hybridization. First morphological alteration was a narrowing of the cortex at 12 and 24 wpi. Morphometry revealed no increase of pyknotic T cells but a decrease of the proliferation rate andflow cytometry showed a reduction of the immature \(CD4^+/CD8^+\) double-positive T cells. Ultrastructural analysis revealed vacuolization, shrinkage, andfinally cytolysis of the cortical epithelial cells and the interdigitating dendritic cells. Immunofluorescence staining exhibited a widespread loss of cortical epithelial cells. This damage to the thymic microenvironment could explain the breakdown of the intrathymic T cell proliferation. It preceded fully developed simian acquired immunodeficiency syndrome and is therefore considered to play a major role in its pathogenesis.
Background
The spectrum of indications for the use of membranes and scaffolds in the field of oral and maxillofacial surgery includes, amongst others, guided bone regeneration (GBR). Currently available membrane systems face certain disadvantages such as difficult clinical handling, inconsistent degradation, undirected cell growth and a lack of stability that often complicate their application. Therefore, new membranes which can overcome these issues are of great interest in this field.
Methods
In this pilot study, we investigated polycaprolactone (PCL) scaffolds intended to enhance oral wound healing by means of melt electrospinning writing (MEW), which allowed for three-dimensional (3D) printing of micron scale fibers and very exact fiber placement. A singular set of box-shaped scaffolds of different sizes consisting of medical-grade PCL was examined and the scaffolds’ morphology was evaluated via scanning electron microscopy (SEM). Each prototype sample with box sizes of 225 μm, 300 μm, 375 μm, 450 μm and 500 μm was assessed for cytotoxicity and cell growth by seeding each scaffold with human osteoblast-like cell line MG63.
Results
All scaffolds demonstrated good cytocompatibility according to cell viability, protein concentration, and cell number. SEM analysis revealed an exact fiber placement of the MEW scaffolds and the growth of viable MG63 cells on them. For the examined box-shaped scaffolds with pore sizes between 225 μm and 500 μm, a preferred box size for initial osteoblast attachment could not be found.
Conclusions
These well-defined 3D scaffolds consisting of medical-grade materials optimized for cell attachment and cell growth hold the key to a promising new approach in GBR in oral and maxillofacial surgery.
Rhabdomyosarcoma (RMS) is the most common malignant soft tissue tumor in children and is highly resistant to all forms of treatment currently available once metastasis or relapse has commenced. As it has recently been determined that the acetylcholine receptor (AChR) γ-subunit, which defines the fetal AChR (fAChR) isoform, is almost exclusively expressed in RMS post partum, we recombinantly fused a single chain variable fragment (scFv) derived from a fully human anti-fAChR Fab-fragment to Pseudomonas exotoxin A to generate an anti-fAChR immunotoxin (scFv35-ETA).While scFv35-ETA had no damaging effect on fAChR-negative control cell lines, it killed human embryonic and alveolar RMS cell lines in vitro and delayed RMS development in a murine transplantation model. These results indicate that scFv35-ETA may be a valuable new therapeutic tool as well as a relevant step towards the development of a fully human immunotoxin directed against RMS. Moreover, as approximately 20% of metastatic malignant melanomas (MMs) display rhabdoid features including the expression of fAChR, the immunotoxin we developed may also prove to be of significant use in the treatment of these more common and most often fatal neoplasms.
Virotherapy using oncolytic vaccinia virus strains is one of the most promising new strategies for cancer therapy. In this study, we analyzed for the first time the therapeutic efficacy of the oncolytic vaccinia virus GLV-1h68 in two human hepatocellular carcinoma cell lines HuH7 and PLC/PRF/5 (PLC) in cell culture and in tumor xenograft models. By viral proliferation assays and cell survival tests, we demonstrated that GLV-1h68 efficiently colonized, replicated in, and did lyse these cancer cells in culture. Experiments with HuH7 and PLC xenografts have revealed that a single intravenous injection (i.v.) of mice with GLV-1h68 resulted in a significant reduction of primary tumor sizes compared to uninjected controls. In addition, replication of GLV-1h68 in tumor cells led to strong inflammatory and oncolytic effects resulting in intense infiltration of MHC class II-positive cells like neutrophils, macrophages, B cells and dendritic cells and in up-regulation of 13 pro-inflammatory cytokines. Furthermore, GLV-1h68 infection of PLC tumors inhibited the formation of hemorrhagic structures which occur naturally in PLC tumors. Interestingly, we found a strongly reduced vascular density in infected PLC tumors only, but not in the non-hemorrhagic HuH7 tumor model. These data demonstrate that the GLV-1h68 vaccinia virus may have an enormous potential for treatment of human hepatocellular carcinoma in man.
No abstract available.
No abstract available.
Abstract
Despite multidisciplinary local and systemic therapeutic approaches, the prognosis for most patients with brain metastases is still dismal. The role of adaptive and innate anti-tumor response including the Human Leukocyte Antigen (HLA) machinery of antigen presentation is still unclear. We present data on the HLA class II-chaperone molecule CD74 in brain metastases and its impact on the HLA peptidome complexity.
We analyzed CD74 and HLA class II expression on tumor cells in a subset of 236 human brain metastases, primary tumors and peripheral metastases of different entities in association with clinical data including overall survival. Additionally, we assessed whole DNA methylome profiles including CD74 promoter methylation and differential methylation in 21 brain metastases. We analyzed the effects of a siRNA mediated CD74 knockdown on HLA-expression and HLA peptidome composition in a brain metastatic melanoma cell line.
We observed that CD74 expression on tumor cells is a strong positive prognostic marker in brain metastasis patients and positively associated with tumor-infiltrating T-lymphocytes (TILs). Whole DNA methylome analysis suggested that CD74 tumor cell expression might be regulated epigenetically via CD74 promoter methylation. CD74\(^{high}\) and TIL\(^{high}\) tumors displayed a differential DNA methylation pattern with highest enrichment scores for antigen processing and presentation. Furthermore, CD74 knockdown in vitro lead to a reduction of HLA class II peptidome complexity, while HLA class I peptidome remained unaffected.
In summary, our results demonstrate that a functional HLA class II processing machinery in brain metastatic tumor cells, reflected by a high expression of CD74 and a complex tumor cell HLA peptidome, seems to be crucial for better patient prognosis.
Background
Mandibular pseudocarcinomatous hyperplasia is a rare and generally benign pathology. We report on one of these rare cases.
Case presentation
The case history of a 73-year-old white man stated that he had a carcinoma of the oropharynx, which was primarily treated with radiotherapy and chemotherapy 4 years prior. As a result of radiotherapy he developed an osteoradionecrosis of his mandible and a consecutive pathological fracture of his left mandibular angle. Subsequent osteosynthesis was performed with a reconstruction plate. When we first saw him, his reconstruction plate was partially exposed with intraoral and extraoral fistulation. The resected bone of his defect-bordering jaw showed the typical pathohistological findings of an intraosseous mandibular pseudocarcinomatous hyperplasia. After a first reconstruction attempt with an iliac crest graft failed, definitive reconstruction of his mandible with a microvascular anastomosed fibula graft was achieved.
Conclusions
Intraosseous pseudocarcinomatous hyperplasia of the mandible is a rare differential diagnosis in maxillofacial surgery. Besides other benign epithelial neoplasms, such as calcifying epithelial odontogenic tumor, squamous odontogenic tumor, or different forms of ameloblastoma, the far more frequent invasive squamous cell carcinoma needs to be excluded. A misinterpretation of pseudocarcinomatous hyperplasia as squamous cell carcinoma must be avoided because it can lead to a massive overtreatment.
Donor CD4\(^+\)Foxp3\(^+\) regulatory T cells (T reg cells) suppress graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (HCT allo-HCT]). Current clinical study protocols rely on the ex vivo expansion of donor T reg cells and their infusion in high numbers. In this study, we present a novel strategy for inhibiting GvHD that is based on the in vivo expansion of recipient T reg cells before allo-HCT, exploiting the crucial role of tumor necrosis factor receptor 2 (TNFR2) in T reg cell biology. Expanding radiation-resistant host T reg cells in recipient mice using a mouse TNFR2-selective agonist before allo-HCT significantly prolonged survival and reduced GvHD severity in a TNFR2-and T reg cell-dependent manner. The beneficial effects of transplanted T cells against leukemia cells and infectious pathogens remained unaffected. A corresponding human TNFR2-specific agonist expanded human T reg cells in vitro. These observations indicate the potential of our strategy to protect allo-HCT patients from acute GvHD by expanding T reg cells via selective TNFR2 activation in vivo.
Background: Tardigrades are multicellular organisms, resistant to extreme environmental changes such as heat, drought, radiation and freezing. They outlast these conditions in an inactive form (tun) to escape damage to cellular structures and cell death. Tardigrades are apparently able to prevent or repair such damage and are therefore a crucial model organism for stress tolerance. Cultures of the tardigrade Milnesium tardigradum were dehydrated by removing the surrounding water to induce tun formation. During this process and the subsequent rehydration, metabolites were measured in a time series by GC-MS. Additionally expressed sequence tags are available, especially libraries generated from the active and inactive state. The aim of this integrated analysis is to trace changes in tardigrade metabolism and identify pathways responsible for their extreme resistance against physical stress. Results: In this study we propose a novel integrative approach for the analysis of metabolic networks to identify modules of joint shifts on the transcriptomic and metabolic levels. We derive a tardigrade-specific metabolic network represented as an undirected graph with 3,658 nodes (metabolites) and 4,378 edges (reactions). Time course metabolite profiles are used to score the network nodes showing a significant change over time. The edges are scored according to information on enzymes from the EST data. Using this combined information, we identify a key subnetwork (functional module) of concerted changes in metabolic pathways, specific for de- and rehydration. The module is enriched in reactions showing significant changes in metabolite levels and enzyme abundance during the transition. It resembles the cessation of a measurablemetabolism (e.g. glycolysis and amino acid anabolism) during the tun formation, the production of storage metabolites and bioprotectants, such as DNA stabilizers, and the generation of amino acids and cellular components from monosaccharides as carbon and energy source during rehydration. Conclusions: The functional module identifies relationships among changed metabolites (e.g. spermidine) and reactions and provides first insights into important altered metabolic pathways. With sparse and diverse data available, the presented integrated metabolite network approach is suitable to integrate all existing data and analyse it in a combined manner.
Anti-EGFR targeted therapy is a potent strategy in the treatment of metastatic colorectal cancer (mCRC) but activating mutations in the KRAS gene are associated with poor response to this treatment. Therefore, KRAS mutation analysis is employed in the selection of patients for EGFR-targeted therapy and various studies have shown a high concordance between the mutation status in primary CRC and corresponding metastases. However, although development of therapy related resistance occurs also in the context of novel drugs such as tyrosine kinase-inhibitors the effect of the anti-EGFR treatment on the KRAS/BRAF mutation status itself in recurrent mCRC has not yet been clarified. Therefore, we analyzed 21mCRCs before/after anti-EGFR therapy and found a pre-/posttherapeutic concordance of the KRAS/BRAF mutation status in 20 of the 21 cases examined. In the one discordant case, further analyses revealed that a tumor mosaicism or multiple primary tumors were present, indicating that anti-EGFR therapy has no influence on KRAS/BRAF mutation status in mCRC. Moreover, as the preselection of patients with a KRASwt genotype for anti-EGFR therapy has become a standard procedure, sample sets such ours might be the basis for future studies addressing the identification of potential anti-EGFR therapy induced genetic alterations apart from KRAS/BRAF mutations.